161 related articles for article (PubMed ID: 21557718)
1. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
[TBL] [Abstract][Full Text] [Related]
2. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M
Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
4. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
5. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
[TBL] [Abstract][Full Text] [Related]
6. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
[TBL] [Abstract][Full Text] [Related]
7. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.
Wagner M; Peterson CG; Ridefelt P; Sangfelt P; Carlson M
World J Gastroenterol; 2008 Sep; 14(36):5584-9; discussion 5588. PubMed ID: 18810778
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level.
Peterson CG; Lampinen M; Hansson T; Lidén M; Hällgren R; Carlson M
Scand J Clin Lab Invest; 2016 Sep; 76(5):393-401. PubMed ID: 27223407
[TBL] [Abstract][Full Text] [Related]
9. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
Peterson CG; Eklund E; Taha Y; Raab Y; Carlson M
Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
[TBL] [Abstract][Full Text] [Related]
10. Role of serological markers of activated eosinophils in inflammatory bowel diseases.
Dainese R; Galliani EA; De Lazzari F; D'Incà R; Mariné-Barjoan E; Vivinus-Nebot MH; Hébuterne X; Sturniolo GC; Piche T
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):393-7. PubMed ID: 22293328
[TBL] [Abstract][Full Text] [Related]
11. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
[TBL] [Abstract][Full Text] [Related]
15. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R
Gut; 2004 Dec; 53(12):1806-12. PubMed ID: 15542519
[TBL] [Abstract][Full Text] [Related]
16. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
17. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
Münch A; Söderholm JD; Ost A; Ström M
Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
[TBL] [Abstract][Full Text] [Related]
18. The production of the eosinophil proteins ECP and EPX/EDN are regulated in a reciprocal manner.
Jönsson UB; Blom K; Stålenheim G; Håkansson LD; Venge P
APMIS; 2014 Apr; 122(4):283-91. PubMed ID: 24738159
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and inflammatory faecal markers in collagenous colitis.
Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
